Assessment of the In Vivo genotoxicity of new lead compounds to treat sickle cell disease

Molecules

Volumn 16, Issue 4, 2011, Pages 2982-2989

  Dos Santos, Jean Leandro ^a   Bosquesi, Priscila Longhin ^a   Varanda, Eliana Aparecida ^a   Lima, Lídia Moreira ^a   Chung, Man Chin ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Genotoxicity assay; Micronucleus; Phthalimide derivatives; Sickle cell

Indexed keywords

INDOLE DERIVATIVE;

ANIMAL; ARTICLE; FEMALE; GENETICS; MALE; MICRONUCLEUS TEST; MOUSE; SALMONELLA; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ANIMALS; FEMALE; INDOLES; MALE; MICE; MICRONUCLEUS TESTS; SALMONELLA;

EID: 79955535119     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16042982     Document Type: Article

References (17)

1. Steinberg, M.H. Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol. Sci. 2006, 27, 204-210.
2. Hanft, V.N.; Fruchtman, S.R.; Pickens, C.V.; Rosse, W.F.; Howard, T.A.; Ware, R.E. Acquired DNA mutations associated with in vivo hydroxyurea exposure. Blood 2000, 95, 3589-3593. (Pubitemid 30428496)
3. Lou, T.F.; Singh, M.; Mackie, A.; Li, W.; Pace, B.S. Hydroxyurea generates nitric oxide in human erythroid cells: Mechanisms for gamma-globin gene activation. Exp. Biol. Med. 2009, 234, 1374-1382.
4. Conran, N.; Oresco-santos, C.; Acosta, H.C.; Fattori, A.; Saad, S.T.; Costa, F.F. Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients. Br. J. Haematol. 2004, 124, 547-554. (Pubitemid 38230601)
5. Haywood, C. Jr.; Beach, M.C.; Bediako, S.; Carroll, C.P.; Lattimer, L.; Jarrett, D.; Lanzkron, S. Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease. Am. J. Hematol. 2011, 86, 85-87.
6. Aliyu, Z.Y.; Tumblin, A.R.; Kato, G.J. Current therapy of sickle cell disease. Haematologica 2005, 90, 7-12.
7. Santos, J.L.; Chung, M.C.; Lima, L.M.; Lanaro, C.; Costa, F.F. Use of phthalimide and/or sulphonamide derivatives in the treatment of diseases which require reducing the TNF-alpha levels and exogenous source of nitric oxide, phthalimide derivatives, sulphonamide derivatives, and a method for obtaining a sulphonamide derivative. PCT Int Appl. BR2008/000386, 12 December 2008.
8. Santos, J.L.; Chung, M.C. Design, synthesis and pharmacological evaluation of hybrid compounds that are potentially active in the treatment of sickle cell disease. Rev. Bras. Hematol. Hemoter. 2010, 32, 341-342.
9. Santos, J.L.; Varanda, E.A.; Lima, L.M.; Chung, M.C. Mutagenicity of new lead compounds to treat sickle cell disease symptoms in Salmonella/microsome assay. Int. J. Mol. Sci. 2010, 11, 779-788.
10. Lee, M.; Kwon, J.; Chung, M.K. Enhanced prediction of potential rodent carcinogenicity by utilizing comet assay and apoptotic assay in combination. Mutat. Res. 2003, 541, 9-19. (Pubitemid 38368654)
11. Juul, T.; Malolepszy, A.; Dybkaer, K.; Kidmose, R.; Rasmussen, J.T.; Andersen, G.R.; Jonhsen, H.E.; Jorgensen, J.E.; Andresen, S.U. The in vivo toxicicty of hydroxyurea depends on its direct target catalase. J. Biol. Chem. 2010, 285, 21411-21415.
12. Flanagan, J.M.; Howard, T.A.; Mortier, N.; Avlasevich, S.L.; Smeltzer, M.P.; Wu, S.; Dertinger, S.D.; Ware, R.E. Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia. Mutat. Res. 2010, 698, 38-42.
13. Burney, S.; Caulfield, J.; Niles, J.; Wishnok, J.; Tannenbaum, S. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. 1999, 424, 37-49. (Pubitemid 29101606)
14. Wink, D.A.; Vodovotz, Y.; Laval, J.; Laval, F.; Dewhirst, W.; Mitchell, J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998, 19, 711-721. (Pubitemid 28376759)
15. Felley-Bosco, E. Role of nitric oxide in genotoxicity: Implication for carcinogenesis. Cancer Metastasis Rev. 1998, 17, 25-37. (Pubitemid 28194644)
16. Lin, W.; Xue, H.; Liu, S.; He, Y.; Fu, J.; Zhou, Z. Genotoxicity of nitric oxide produced from sodium nitroprusside. Mutat. Res. 1998, 339, 73-89.
17. Hayashi, M.; Morita, T.; Kodama, Y.; Sofuni, T.; Ishidate, M.J. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 1990, 245, 245-249.